International Journal of Medical and Pharmaceutical Research
2026, Volume-7, Issue 3 : 2068-2072
Research Article
Endothelial Cell Count Changes at 1 Week and 6 Weeks After Small Incision Cataract Surgery (SICS)
 ,
Received
March 13, 2026
Accepted
May 18, 2026
Published
May 29, 2026
Abstract

Background: Small Incision Cataract Surgery (SICS) is the preferred technique in high-volume settings across India and the developing world. Corneal endothelial cell loss is a key measure of surgical trauma and long-term corneal health.

Aim: To evaluate corneal endothelial cell count changes at 1 week and 6 weeks following SICS using the irrigating vectis technique.

Methods: A prospective observational study of 50 eyes undergoing SICS for senile cataract was conducted at Ahalia Foundation Eye Hospital from January to November 2012. Endothelial cell density (ECD) was measured by non-contact specular microscopy (Konan NSP-7700) preoperatively and at 1 week and 6 weeks postoperatively.

Results: Mean preoperative ECD was 2689 ± 222 cells/mm². At 1 week, mean cell loss was 132 cells (4.92%). At 6 weeks, mean cell loss was 258 cells (9.61%) with a mean ECD of 2430 ± 284 cells/mm². The difference was statistically significant (p < 0.05).

Conclusion: SICS using the irrigating vectis technique causes an endothelial cell loss of approximately 9.59% at 6 weeks, which is clinically acceptable and comparable to published data for phacoemulsification, making SICS a safe and viable alternative in resource-limited settings.

Keywords
INTRODUCTION

Cataract remains the leading cause of reversible blindness worldwide, accounting for nearly half of all cases of visual impairment globally.[1] More than 90% of the visually impaired live in developing countries, where cost-effective, high-volume surgical strategies are essential.[2] In India alone, approximately five million cataract surgeries are performed each year, making the choice of surgical technique a matter of substantial public health importance.[3]

 

Small Incision Cataract Surgery (SICS), performed through a scleral tunnel incision, has emerged as the preferred technique in high-volume settings because it combines the benefits of extracapsular surgery with the advantages of self-sealing wound architecture: reduced astigmatism, rapid visual rehabilitation, machine independence and lower cost.[4,5] The irrigating vectis technique of nucleus delivery is widely favoured within SICS because of its relative simplicity and gentle handling of the anterior chamber.

 

The corneal endothelium, a non-regenerating monolayer of hexagonal cells, is responsible for maintaining corneal transparency through its pump-barrier function. Endothelial cell density (ECD) declines naturally with age from approximately 3000–3500 cells/mm² in young adults to 1500–2000 cells/mm² in the elderly.[6] Any intraocular surgical procedure causes further, irreversible cell loss. When ECD falls below 400–500 cells/mm², the functional reserve is insufficient to maintain corneal deturgescence, resulting in bullous keratopathy.[7]

 

Specular microscopy, introduced by Maurice in 1968 and developed for clinical use by Laing in 1975, allows non-invasive quantification of ECD and morphological parameters (pleomorphism, polymegathism) both pre- and postoperatively.[8] Multiple studies have evaluated endothelial cell loss after SICS, but reported figures vary widely owing to differences in nucleus delivery technique, cataract grade, and inclusion criteria.[9,10]

 

The present study was designed to prospectively quantify endothelial cell changes at two postoperative time-points, 1 week and 6 weeks, following SICS performed exclusively by the irrigating vectis technique, in a defined cohort of senile cataract patients with preoperatively normal endothelia.

 

MATERIALS AND METHODS

Study Design and Setting

This was a prospective observational study conducted at Ahalia Foundation Eye Hospital, Palakkad, Kerala - a JCI-accredited tertiary eye care centre. Patients were recruited consecutively from the outpatient department and surgical camps from January 2012 to November 2012. The study was conducted in accordance with the Declaration of Helsinki and institutional ethical standards; all participants provided written informed consent.

 

Inclusion and Exclusion Criteria

Patients aged 40 years and above undergoing SICS for senile cataract with a morphologically normal corneal endothelium on specular microscopy were enrolled. Eyes with corneal pathology, pseudoexfoliation, diabetes mellitus, uveitis, glaucoma, vitreoretinal disease, prior intraocular surgery, nuclear sclerosis grade 4 or above (LOCS III), traumatic cataract, or any intraoperative complication such as posterior capsule rent or vitreous loss were excluded.

 

Surgical Technique

All surgeries were performed by a single experienced surgeon. After peribulbar anaesthesia (5 mL of 2% lidocaine hydrochloride with 1:20,000 adrenaline), a fornix-based conjunctival flap was fashioned at the superior limbus. A 6 mm frown scleral incision was placed 1.5 mm posterior to the limbus; a sclerocorneal tunnel was created with a stainless-steel crescent blade. A side-port was made at 3 or 9 o'clock based on surgeon preference. The anterior chamber was filled with HPMC 2%, and a continuous curvilinear capsulorrhexis (CCC) was created with a 26 G bent needle. An anterior chamber entry was made with a 3.2 mm keratome and extended with an extension blade. Hydrodissection was performed with Ringer's Lactate. After nuclear rotation and delivery into the anterior chamber using a Sinskey hook with OVD support, the nucleus was removed by the irrigating vectis technique. Cortical clean-up was accomplished with a coaxial irrigation-aspiration cannula. A PMMA posterior chamber IOL was implanted in the capsular bag. OVD was meticulously aspirated, and a subconjunctival injection of gentamicin 10 mg and dexamethasone 2 mg was administered.

 

Endothelial Cell Assessment

Endothelial cell density (cells/mm²) was measured with a Konan Non-Con ROBO Specular Microscope X (NSP-7700) preoperatively and at 1 week and 6 weeks postoperatively. An average of five readings was taken at each visit; the automated cell-counting algorithm supplied by the manufacturer's software was used as the primary analysis method. A variable-frame (manual) count of 50 cells was additionally performed preoperatively and at 6 weeks to corroborate automated findings. Percentage endothelial cell loss was calculated as: [(Preoperative ECD − Postoperative ECD) / Preoperative ECD] × 100.

 

Statistical Analysis

Data are presented as mean ± standard deviation (SD). The paired Student's t-test was used to compare mean ECD between preoperative baseline and each postoperative time-point. A p-value < 0.05 was considered statistically significant. All analyses were performed using standard statistical software.

 

RESULTS

Demographic Characteristics

A total of 50 eyes of 50 patients were studied. The mean age was 64.5 years (range 55–75 years). There were 18 males (36%) and 32 females (64%). The majority of patients (21 eyes, 42%) were in the 61–70-year age group, reflecting the peak incidence of senile cataract in this population. Demographic data are summarised in Table 1.

 

Parameter

Category

n (%)

Age group (years)

< 50

0 (0%)

 

51 – 60

19 (38%)

 

61 – 70

21 (42%)

 

> 70

10 (20%)

Mean age (years)

64.5

Sex

Male

18 (36%)

 

Female

32 (64%)

Cataract type (NS only)

Nuclear Sclerosis

21 (42%)

 

PSC only

6 (12%)

 

Mixed / CC

23 (46%)

Table 1. Demographic Profile of Study Patients (SICS Group, n = 50)

NS = Nuclear Sclerosis; PSC = Posterior Subcapsular Cataract; CC = Cortical Cataract

 

Endothelial Cell Density: Summary Statistics

The mean preoperative ECD was 2688.8 ± 222.2 cells/mm². At 1 week postoperatively, mean ECD was 2556.6 cells/mm², representing a mean loss of 132.2 cells (4.92%). At 6 weeks, mean ECD was 2430.5 ± 283.8 cells/mm² — a mean loss of 258.4 cells (9.61%) from baseline. Summary statistics are presented in Table 2.

 

Parameter

Preoperative

1 Week Post-op

6 Weeks Post-op

Mean ECD (cells/mm²)

2688.8

2556.6

2430.5

SD (cells/mm²)

222.2

242.2

283.8

Mean cell loss (cells)

132.2

258.4

% cell loss

4.92%

9.61%

p-value (vs preop)

< 0.05*

< 0.05*

Table 2. Mean Endothelial Cell Density (ECD) at Preoperative, 1-Week, and 6-Week Visits (SICS, n = 50)

*Paired Student's t-test. ECD = Endothelial Cell Density; SD = Standard Deviation

 

Percentage Cell Loss by Time Point

The mean percentage endothelial cell loss at 1 week was 4.92%, increasing to 9.61% at 6 weeks. This pattern is consistent with an early post-surgical inflammatory phase followed by progressive cell loss and remodelling during the first 6 weeks. Table 3 presents percentage cell loss data across both time-points.

 

Time Point

Mean Cell Loss (cells/mm²)

Mean % Cell Loss

1 Week

132.2

4.92%

6 Weeks

258.4

9.61%

Table 3. Mean Percentage Endothelial Cell Loss at 1 Week and 6 Weeks Post-SICS

 

Individual Patient Data

Table 4 presents the complete individual patient data for all 50 eyes, including preoperative ECD, 1-week and 6-week postoperative ECD, and cataract morphology.

 

Sl. No.

Patient

Age

Sex

Pre-op ECD

1-Wk ECD

6-Wk ECD

Cataract

1

Patient 01

58

F

2733

2705

2700

NS2

2

Patient 02

55

M

2543

2500

2462

NS3

3

Patient 03

71

F

2842

2670

2476

NS2PSC

4

Patient 04

56

F

2803

2766

2635

NS2

5

Patient 05

62

F

2823

2766

2698

PSC

6

Patient 06

58

M

2991

2852

2447

CCNS2

7

Patient 07

70

M

2750

2500

2314

NS2

8

Patient 08

72

F

2673

2398

2056

NS2PSC

9

Patient 09

66

F

2491

2376

2345

CCNS3

10

Patient 10

62

F

2557

2456

2373

PSC

11

Patient 11

67

F

2662

2427

2319

NS2

12

Patient 12

65

M

2432

2376

2300

NS3PSC

13

Patient 13

71

M

2598

2480

2405

CCNS2

14

Patient 14

55

M

2278

2262

2230

NS3

15

Patient 15

66

F

2868

2467

2280

PSC

16

Patient 16

70

F

3063

3000

2999

CCNS2PSC

17

Patient 17

60

F

2891

2667

2465

NS1PSC

18

Patient 18

75

F

2423

2489

2137

PSC

19

Patient 19

58

M

2868

2645

2577

NS2PSC

20

Patient 20

63

F

2824

2789

2717

CCNS1

21

Patient 21

55

F

3208

3190

3145

NS3

22

Patient 22

69

F

2924

2857

2761

NS2

23

Patient 23

68

F

2712

2700

2699

CCPSC

24

Patient 24

62

F

2703

2687

2584

NS1PSC

25

Patient 25

68

F

2570

2395

2289

PSC

26

Patient 26

60

F

2693

2656

2555

NS3

27

Patient 27

55

F

2913

2879

2678

NS3

28

Patient 28

68

M

2820

2513

2356

CCNS2

29

Patient 29

67

F

2065

1897

1676

NS1PSC

30

Patient 30

57

M

2796

2561

2397

NS3

31

Patient 31

75

M

2884

2803

2752

NS2

32

Patient 32

64

F

2448

2221

2068

NS2PSC

33

Patient 33

65

M

2909

2563

2118

NS1PSC

34

Patient 34

72

M

2732

2580

2378

NS3

35

Patient 35

75

F

2564

2465

2374

NS2

36

Patient 36

72

F

2463

2318

2290

NS2

37

Patient 37

60

F

2538

2407

2396

NS1PSC

38

Patient 38

65

M

2646

2542

2488

NS3

39

Patient 39

58

F

2196

2150

2065

NS3PSC

40

Patient 40

60

M

2949

2783

2647

PSC

41

Patient 41

60

F

2623

2565

2510

NS2

42

Patient 42

75

F

2616

2599

2542

NS2PSC

43

Patient 43

70

M

2783

2658

2516

CCNS3

44

Patient 44

68

F

2955

2765

2679

NS3

45

Patient 45

75

M

2640

2000

1586

NS2

46

Patient 46

55

F

2342

2300

2238

CCNS2

47

Patient 47

60

F

2653

2584

2365

CCNS3

48

Patient 48

60

M

2541

2250

2151

NS2PSC

49

Patient 49

60

F

2625

2562

2496

NS3

50

Patient 50

68

M

2817

2789

2789

NS2

 

MEAN

64.5

 

2688.8

2556.6

2430.5

 

Table 4. Individual Patient Endothelial Cell Counts (SICS, Automated Method)

ECD = Endothelial Cell Density (cells/mm²). NS = Nuclear Sclerosis; PSC = Posterior Subcapsular Cataract; CC = Cortical Cataract

 

DISCUSSION

The present study documents a mean endothelial cell loss of 4.92% at 1 week and 9.61% at 6 weeks following SICS using the irrigating vectis technique. These figures are consistent with the range of 4–17% loss reported in the literature for SICS and indicate a clinically acceptable degree of endothelial trauma.[11]

 

The pattern of loss observed - with the bulk of cell death occurring within the first week and continued, though slower, loss thereafter - is consistent with the natural history of endothelial injury described by Schultz et al.[12] Early loss is attributable to direct mechanical trauma from intraocular instrumentation, brief nucleus–endothelium proximity during anterior-chamber manoeuvres, and the acute inflammatory response. Continued cell loss between 1 and 6 weeks may reflect ongoing wound healing, the effects of prolonged postoperative inflammation, or the lag in specular microscopic detection of injured but not immediately lost cells.

 

Studies employing different nucleus delivery strategies for SICS have reported correspondingly different levels of endothelial loss. Thakur et al. found a loss of 15.83% at 1 month using the same irrigating vectis technique, but included mature and hard cataracts in their series.9 Wright and Chawla reported a 16% loss using the anterior chamber (AC) maintainer technique.[13] Vajpayee et al. recorded 17.66% at 3 months with the phacofracture approach, and Gogate et al. documented 15.3% at 6 weeks using visco-expression.[10,14] The lower loss in the present study (9.59% at 6 weeks) is attributable to the exclusion of grade 4 and above cataracts and to the inherent gentleness of the irrigating vectis, which limits the duration of nuclear manipulation within the anterior chamber.

 

George et al. and Sasikumar et al. reported even lower losses of 6.07% and 4.21% respectively at comparable time-points, both series being restricted to early immature cataracts (NS grades 1–3).[11,15] The inclusion in the current study of PSC and combined morphologies (NS+PSC, cortical cataract) accounts for the modestly higher mean loss. Harder nuclei require greater intraocular manipulation, generate more mechanical shear at the endothelium, and increase the duration of AC irrigation.

 

The incremental increase in cell loss between week 1 (4.91%) and week 6 (9.59%) underscores the importance of the 6-week time-point as the minimum follow-up for accurate assessment. Studies with only 1-week follow-up will systematically underestimate the definitive endothelial impact of SICS. The gradual decrease in the rate of loss after 6 weeks, as documented in longer-term studies, suggests that the figures reported here represent near-maximal early loss attributable to the procedure itself.[8]

 

Limitations of this study include a sample size of 50 eyes, a relatively short maximum follow-up of 6 weeks, and the absence of morphometric data (coefficient of variation, percentage hexagonality) beyond cell density. A larger study with longer follow-up, including 3- and 12-month assessments and morphometric indices, would provide a more complete characterisation of the endothelial response to SICS.

 

CONCLUSIONS

SICS using the irrigating vectis technique results in a mean endothelial cell loss of 4.92% at 1 week and 9.61% at 6 weeks postoperatively in patients with senile cataract of up to LOCS III grade 3. This degree of endothelial trauma is clinically acceptable and falls within published ranges for phacoemulsification. The irrigating vectis technique appears to be among the least traumatic nucleus delivery methods for SICS and should be favoured in settings where phacoemulsification is unavailable or cost-prohibitive. A larger, longer-term study incorporating morphometric endothelial parameters is warranted to confirm these findings.

 

Acknowledgement

I would like to express my sincere gratitude to Dr. Satyajit M V for his invaluable guidance throughout this study. His insightful feedback and expertise were instrumental in shaping this research.

 

REFERENCES

  1. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ 2004;82(11):844-51.
  2. Thylefors B. A simplified methodology for the assessment of blindness and its main causes. World Health Stat Q 1987;40(2):129-41.
  3. Gogate P, Deshpande M, Nirmalan PK. Why do phacoemulsification? Manual small incision cataract surgery is almost as effective, but less expensive. Ophthalmology 2007;114(5):965-8.
  4. Ruit S, Tabin G, Chang D, et al. A prospective randomised clinical trial of phacoemulsification versus manual sutureless small-incision extracapsular cataract surgery in Nepal. Am J Ophthalmol 2007;143(1):32-8.
  5. Gogate PM, Kulkarni SR, Deshpande RD, et al. Safety and efficacy of phacoemulsification compared with manual small-incision cataract surgery by a randomised controlled clinical trial: six-week results. Ophthalmology 2005;112(5):869-74.
  6. Yee RW, Matsuda M, Schultz RO, et al. Changes in the normal corneal endothelial cellular pattern as a function of age. Curr Eye Res 1985;4(6):671-7.
  7. Geroski DH, Matsuda M, Yee RW, et al. Pump function of the human corneal endothelium: effects of age and corneal guttata. Ophthalmology 1985;92(6):759-63.
  8. Laing RA. Clinical specular microscopy. Arch Ophthalmol 1979;97(9):1714-9.
  9. Thakur SKD, Dan A, Singh M, et al. Endothelial cell loss after SICS. Nepal J Ophthalmol 2011;3(6):177-80.
  10. Gogate P, Ambardekar P, Kulkarni S, et al. Comparison of endothelial cell loss after cataract surgery: phacoemulsification versus manual small-incision cataract surgery - six-week results of a randomised controlled trial. J Cataract Refract Surg 2010;36(2):247-53.
  11. George R, Rupauliha P, Sripriya AV, et al. Comparison of endothelial cell loss and surgically induced astigmatism following conventional extracapsular cataract surgery, manual small-incision surgery and phacoemulsification. Ophthalmic Epidemiol 2005;12(5):293-7.
  12. Schultz RO, Glasser DB, Matsuda M, et al. Response of the corneal endothelium to cataract surgery. Arch Ophthalmol 1986;104(8):1164-9.
  13. Wright M, Chawla H. Results of small incision extracapsular cataract surgery using anterior chamber maintainer without viscoelastic. Br J Ophthalmol 1999;83(1):71-5.
  14. Vajpayee RB, Sabarwal S, Sharma N, et al. Phacofracture versus phacoemulsification in eyes with age-related cataract. J Cataract Refract Surg. 1998;24(12):1252-5.
  15. Sasikumar D, Gopal MRS, Sonia M, et al. Endothelial cell loss after phacoemulsification and manual small incision cataract surgery - a comparison. In: Lavanagia BC, ed. Proceedings of All India Ophthalmologic Conference 2001;59(2):177-8.
Recommended Articles
Research Article Open Access
Functional Outcome of Intramedullary Interlocking Nail in Fractures of Shaft of Humerus: A Prospective Interventional Study
2026, Volume-7, Issue 3 : 1980-1983
Review Article Open Access
Clinical Utility of Artificial Intelligence in Early Cancer Detection: A Systematic Review and Meta-Analysis of Solid Tumors
2026, Volume-7, Issue 3 : 2055-2061
Research Article Open Access
Premenstrual Dysphoric Disorder: Prevalence and Its Impact on Quality of Life Among Female Nursing Students in a University in Kanpur
2026, Volume-7, Issue 3 : 1993-2001
Review Article Open Access
Artificial Intelligence Assisted Early Detection of Solid Tumors: Systematic Review and Meta-Analytic Evidence
2026, Volume-7, Issue 3 : 2062-2067
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-7, Issue 3
Citations
5 Views
8 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved